China BCT Announces Conference Call to Discuss Third Quarter and Nine Month FY2012 Results

2012-11-13 21:00 1012

LIUZHOU, China, November 13, 2012 /PRNewswire/ -- China BCT Pharmacy Group, Inc., (OTC BB: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Wednesday, November 14, 2012 to discuss its third quarter and nine month FY2012 results.

Mr. Huitian Tang, Chief Executive Officer of the Company, and Ms. Shelly Zhang, Chief Financial Officer of the Company, will host the conference call. The Company will release its financial results for the third quarter and nine months to September 30, 2012 prior to the call.

The conference call can be accessed by dialing 866-759-2078 (U.S. and Canada callers) or 706-643-0585 (international callers) and entering the conference ID 70856824 approximately five to ten minutes prior to the call. A replay will be available for two weeks starting on Wednesday, November 14, 2012 at 11:00 a.m. ET by dialing 855-859-2056 (U.S. and Canada callers) or 404-537-3406 (international callers) and entering the conference replay ID 70856824.

About China BCT

China BCT is engaged in pharmaceutical distribution, pharmacy retailing, and the manufacture of pharmaceuticals products through its subsidiaries Guangxi Liuzhou Baicaotang Medicine Limited, Guangxi Liuzhou Baicaotang Medicine Retail Limited, and Hefeng Pharmaceutical Co. Limited in Guangxi province, China. It operates a large regional retail network in Guangxi province, consisting of 195 directly owned retail stores in Guangxi province and currently over 8,000 products are distributed through the Company's wholesale distribution network. For more information, please visit

Company Contact:
Ms. Shelly Zhang, Chief Financial Officer
China BCT Pharmacy Group, Inc.
Tel: +86-772-363-8318

Investor Relations Contact:
Mark Collinson, Partner
CCG Investor Relations
Tel: +1-310-954-1343

Source: China BCT Pharmacy Group, Inc.